Distinct Recurrence Risk Factors for Intrahepatic Metastasis and Multicenter Occurrence After Surgery in Patients with Hepatocellular Carcinoma

Overview

Journal J Gastrointest Surg

Specialty Gastroenterology

Date 2016 Nov 6

PMID 27815759

Citations 27

Authors

Shenghua Hao

Ping Fan

Shaofei Chen

Caixue Tu

Chidan Wan

Affiliations

Soon will be listed here.

Abstract

Background And Objectives: Intrahepatic recurrence after hepatectomy for hepatocellular carcinoma (HCC) includes intrahepatic metastasis (IM) and multicenter occurrence (MO). The risk factors for these two types of intrahepatic recurrence have not been well defined.

Methods: The type of intrahepatic recurrence was determined based on histopathological features of 93 HCC patients who underwent a repeat hepatectomy for recurrent HCC. Various clinical and pathological factors were analyzed to define distinct risk factors for different types of intrahepatic recurrence.

Results: The recurrence rates at 1, 2, 3, 5, and 8 years postoperatively were 22.4, 42.9, 61.2, 85.7, and 100 %, respectively, in patients with IM and 5.0, 25.0, 45.5, 67.5, and 100 %, respectively, in patients with MO (p = 0.005). A total of 16 clinical and pathological factors were tested in univariable and multivariable analyses. We found that large-size tumor (>5 cm), multiple tumors (two or more), and vascular invasion were significantly associated with IM recurrence, and liver cirrhosis and Ishak hepatic inflammatory activity were highly associated with MO recurrence. In addition, blood transfusion and a high hepatitis B virus (HBV)-DNA load (>2000 IU/ml) were independent risk factors common to both IM and MO recurrences.

Conclusions: IM and MO recurrences were associated with distinct risk factors, while blood transfusion and high HBV-DNA load (>2000 IU/ml) were independent risk factors common to both IM and MO recurrences.

Citing Articles

Therapeutic efficacy and prognostic indicators in re-resection for recurrent hepatocellular carcinoma: Insights from a retrospective study.

Fan Q, Wei P, Ma D, Cheng Q, Gao J, Zhu J Surg Open Sci. 2025; 23():16-23.

PMID: 39816698 PMC: 11733202. DOI: 10.1016/j.sopen.2024.12.004.

Prognostic significance of early and multiple recurrences after curative resection for hepatocellular carcinoma.

Tanemura A, Noguchi D, Shinkai T, Ito T, Hayasaki A, Gyoten K BMC Surg. 2024; 24(1):339.

PMID: 39468556 PMC: 11520444. DOI: 10.1186/s12893-024-02642-6.

Clinical Nomogram Model for Pre-Operative Prediction of Microvascular Invasion of Hepatocellular Carcinoma before Hepatectomy.

Chen J, Chen Y, Hsieh K, Lee H, Chen C, Chen J Medicina (Kaunas). 2024; 60(9).

PMID: 39336451 PMC: 11433876. DOI: 10.3390/medicina60091410.

Deficiency of SIAH1 promotes the formation of filopodia by increasing the accumulation of FASN in liver cancer.

Liu Z, Hu Q, Cao K, Sun J, Cui L, Ji M Cell Death Dis. 2024; 15(7):537.

PMID: 39075049 PMC: 11286965. DOI: 10.1038/s41419-024-06929-7.

Anatomic versus non-anatomic liver resection for hepatocellular carcinoma-A European multicentre cohort study in cirrhotic and non-cirrhotic patients.

Zeindler J, Hess G, von Heesen M, Aegerter N, Reber C, Schmitt A Cancer Med. 2024; 13(5):e6981.

PMID: 38477510 PMC: 10935881. DOI: 10.1002/cam4.6981.

References

EDMONDSON H, STEINER P . Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer. 1954; 7(3):462-503. DOI: 10.1002/1097-0142(195405)7:3<462::aid-cncr2820070308>3.0.co;2-e. View

Makino Y, Yamanoi A, Kimoto T, Kohno H, Nagasue N . The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma. Am J Gastroenterol. 2000; 95(5):1294-300. DOI: 10.1111/j.1572-0241.2000.02028.x. View

Portolani N, Coniglio A, Ghidoni S, Giovanelli M, Benetti A, Tiberio G . Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg. 2006; 243(2):229-35. PMC: 1448919. DOI: 10.1097/01.sla.0000197706.21803.a1. View

Vamvakas E, Blajchman M . Transfusion-related immunomodulation (TRIM): an update. Blood Rev. 2007; 21(6):327-48. DOI: 10.1016/j.blre.2007.07.003. View

Chen P, Chen D, Lai M, Chang M, Huang G, Yang P . Clonal origin of recurrent hepatocellular carcinomas. Gastroenterology. 1989; 96(2 Pt 1):527-9. DOI: 10.1016/0016-5085(89)91581-3. View

Wang J, Li Q, Sun Y, Zheng H, Cui Y, Li H . Clinicopathologic features between multicentric occurence and intrahepatic metastasis of multiple hepatocellular carcinomas related to HBV. Surg Oncol. 2008; 18(1):25-30. DOI: 10.1016/j.suronc.2008.05.009. View

Okada S, Ishii H, Nose H, Okusaka T, Kyogoku A, YOSHIMORI M . Intratumoral DNA heterogeneity of small hepatocellular carcinoma. Cancer. 1995; 75(2):444-50. DOI: 10.1002/1097-0142(19950115)75:2<444::aid-cncr2820750206>3.0.co;2-p. View

Saeki R, Nagai H, Kaneko S, Unoura M, Yamanaka N, Okamoto E . Intratumoral genomic heterogeneity in human hepatocellular carcinoma detected by restriction landmark genomic scanning. J Hepatol. 2000; 33(1):99-105. DOI: 10.1016/s0168-8278(00)80165-8. View

Goubran H, Sabry W, Kotb R, Seghatchian J, Burnouf T . Platelet microparticles and cancer: An intimate cross-talk. Transfus Apher Sci. 2015; 53(2):168-72. DOI: 10.1016/j.transci.2015.10.014. View

10.

Yamamoto J, Kosuge T, Takayama T, Shimada K, Yamasaki S, Ozaki H . Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery. 1994; 115(3):303-9. View

11.

Blajchman M . Immunomodulatory effects of allogeneic blood transfusions: clinical manifestations and mechanisms. Vox Sang. 1998; 74 Suppl 2:315-9. DOI: 10.1111/j.1423-0410.1998.tb05437.x. View

12.

van Gulik T, de Graaf W, Dinant S, Busch O, Gouma D . Vascular occlusion techniques during liver resection. Dig Surg. 2007; 24(4):274-81. DOI: 10.1159/000103658. View

13.

Friemel J, Rechsteiner M, Frick L, Bohm F, Struckmann K, Egger M . Intratumor heterogeneity in hepatocellular carcinoma. Clin Cancer Res. 2014; 21(8):1951-61. DOI: 10.1158/1078-0432.CCR-14-0122. View

14.

Cherqui D, Laurent A, Mocellin N, Tayar C, Luciani A, Tran Van Nhieu J . Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation. Ann Surg. 2009; 250(5):738-46. DOI: 10.1097/SLA.0b013e3181bd582b. View

15.

Matsuda M, Fujii H, Kono H, Matsumoto Y . Surgical treatment of recurrent hepatocellular carcinoma based on the mode of recurrence: repeat hepatic resection or ablation are good choices for patients with recurrent multicentric cancer. J Hepatobiliary Pancreat Surg. 2001; 8(4):353-9. DOI: 10.1007/s005340170008. View

16.

Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S . Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol. 2003; 38(2):200-7. DOI: 10.1016/s0168-8278(02)00360-4. View

17.

Cucchetti A, Piscaglia F, Caturelli E, Benvegnu L, Vivarelli M, Ercolani G . Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. Ann Surg Oncol. 2008; 16(2):413-22. DOI: 10.1245/s10434-008-0232-4. View

18.

Regimbeau J, Abdalla E, Vauthey J, Lauwers G, Durand F, Nagorney D . Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study. J Surg Oncol. 2003; 85(1):36-41. DOI: 10.1002/jso.10284. View

19.

Arii S, Monden K, Niwano M, Furutani M, Mori A, Mizumoto M . Results of surgical treatment for recurrent hepatocellular carcinoma; comparison of outcome among patients with multicentric carcinogenesis, intrahepatic metastasis, and extrahepatic recurrence. J Hepatobiliary Pancreat Surg. 1998; 5(1):86-92. DOI: 10.1007/pl00009956. View

20.

Tung-Ping Poon R, Fan S, Wong J . Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg. 2000; 232(1):10-24. PMC: 1421103. DOI: 10.1097/00000658-200007000-00003. View